1239576-18-1Relevant articles and documents
Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazoles
Ratcliffe, Paul,Abernethy, Lynn,Ansari, Nasrin,Cameron, Ken,Clarkson, Tom,Dempster, Maureen,Dunn, David,Easson, Anna-Marie,Edwards, Darren,Everett, Katy,Feilden, Helen,Ho, Koc-Kan,Kultgen, Steve,Littlewood, Peter,MacLean, John,McArthur, Duncan,McGregor, Deborah,McLuskey, Hazel,Neagu, Irina,Nimz, Olaf,Nisbet, Lesley-Anne,Ohlmeyer, Michael,Palin, Ronnie,Pham, Quynhchi,Rong, Yajing,Roughton, Andrew,Sammons, Melanie,Swanson, Robert,Tracey, Heather,Walker, Glenn
, p. 4652 - 4657 (2011/09/12)
Systematic optimisation of a poorly soluble lead series of isoxazole-3-carboxamides was conducted. Substitution of the 4-position with specific polar functionality afforded the requisite balance of potency, solubility and physicochemical properties. Compo
ISOXAZOLE-5-CARBOXAMIDE DERIVATIVES
-
Page/Page column 18-19, (2010/08/18)
The present invention relates to isoxazole-5-carboxamide derivative having the general Formula (I), or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same, as well as to the use of said isoxazole-5-carboxamide de